Professional Overview
Tina Gullotta is an accomplished finance executive with over 25 years of experience in the biotechnology and technology industries. As the Vice President of Finance at Frontier Medicines, she leverages her deep expertise in corporate finance, accounting, and investor relations to drive financial strategy and operational excellence.
Experience Summary
Current Role
As the Vice President of Finance at Frontier Medicines, Tina is responsible for leading the company's financial operations, including financial planning and analysis, treasury management, and corporate reporting. She plays a key role in supporting Frontier's growth as a leading biopharmaceutical company focused on developing novel therapies for challenging diseases.
Career Progression
Prior to her current role, Tina served as the Vice President of Finance and Corporate Controller at Sunesis Pharmaceuticals, where she was instrumental in improving financial controls and processes, as well as enhancing the company's investor communication and transparency. Earlier in her career, Tina held finance leadership positions at Atara Biotherapeutics, Gap Inc., and Network Equipment Technologies, where she demonstrated her ability to drive operational efficiencies and contribute to organizational growth.
Academic Background
Tina holds a Bachelor of Science degree in Accounting from the University of California, Berkeley. She is a Certified Public Accountant and has completed executive education programs at Stanford University and the University of Pennsylvania's Wharton School.
Areas of Expertise
- Corporate finance and accounting
- Financial planning and analysis
- Treasury and cash management
- Investor relations and capital markets
- Financial reporting and compliance
- Process improvement and operational optimization
- Cross-functional collaboration and leadership
Professional Impact
Throughout her career, Tina has made significant contributions to the organizations she has served. At Sunesis Pharmaceuticals, she played a crucial role in enhancing financial controls and processes, leading to improved financial reporting and decision-making. Additionally, her expertise in investor relations and communication helped the company strengthen its relationships with the investment community.
Conclusion
Tina Gullotta is a seasoned finance executive with a proven track record of driving financial strategy, operational excellence, and organizational growth. Her deep industry knowledge, technical expertise, and collaborative leadership style make her a valuable asset to Frontier Medicines as the company continues to advance its pipeline of innovative therapies.
